Cargando…
Trabectome surgery for primary and secondary open angle glaucomas
PURPOSE: In most forms of open angle glaucoma, the trabecular meshwork is the main barrier for aqueous humor outflow, causing elevated intraocular pressure (IOP). The Trabectome is a minimal invasive device for the surgical treatment of open angle glaucoma, particularly eliminating the juxtacanalicu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889259/ https://www.ncbi.nlm.nih.gov/pubmed/24158374 http://dx.doi.org/10.1007/s00417-013-2500-7 |
_version_ | 1782299168979550208 |
---|---|
author | Jordan, Jens F. Wecker, Thomas van Oterendorp, Christian Anton, Alexandra Reinhard, Thomas Boehringer, Daniel Neuburger, Matthias |
author_facet | Jordan, Jens F. Wecker, Thomas van Oterendorp, Christian Anton, Alexandra Reinhard, Thomas Boehringer, Daniel Neuburger, Matthias |
author_sort | Jordan, Jens F. |
collection | PubMed |
description | PURPOSE: In most forms of open angle glaucoma, the trabecular meshwork is the main barrier for aqueous humor outflow, causing elevated intraocular pressure (IOP). The Trabectome is a minimal invasive device for the surgical treatment of open angle glaucoma, particularly eliminating the juxtacanalicular meshwork. This study was conducted to compare the effectiveness and complication profile among different glaucoma subgroups. METHODS: Single center prospective observational study. There were 557 consecutive eyes of 487 patients included in this study. Trabectome surgery was performed either alone or in combination with cataract surgery. Intraoperative and postoperative complications were documented systematically. Main outcome measures were IOP reduction over time and the preoperative and postoperative number of IOP-lowering medications. Due to subgroup sizes, only data from eyes with primary open angle glaucoma and pseudoexfoliation glaucoma were processed for statistical analysis. RESULTS: For the 261 eyes classified as primary open angle glaucoma, preoperative IOP was 24 ± 5.5 mmHg (mean ± SD) under 2.1 ± 1.3 IOP-lowering medications. After a mean follow-up of 204 ± 238 days, IOP was reduced to 18 ± 6.1 mmHg, and medication was reduced to 1.2 ± 1.1. For the 173 eyes classified as pseudoexfoliation glaucoma, after a mean follow-up of 200 ± 278 days, IOP was reduced from 25 ± 5.9 mmHg to 18 ± 8.2 mmHg, and medication was reduced from 2.0 ± 1.2 to 1.1 ± 1.1. A Cox proportional hazards model hinted forward superiority of the combined surgery cases (Trabectome + Phaco + intraocular lens) in comparison to Trabectome surgery only in phakic or pseudophakic eyes. No serious complications were observed. CONCLUSIONS: Minimal invasive glaucoma surgery with the Trabectome seems to be safe and effective. The subgroup analysis of different kinds of open angle glaucomas presented in this study may help in first-line patient selection. The lack of ocular surface alterations makes it a valuable addition to glaucoma surgery. |
format | Online Article Text |
id | pubmed-3889259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-38892592014-01-14 Trabectome surgery for primary and secondary open angle glaucomas Jordan, Jens F. Wecker, Thomas van Oterendorp, Christian Anton, Alexandra Reinhard, Thomas Boehringer, Daniel Neuburger, Matthias Graefes Arch Clin Exp Ophthalmol Glaucoma PURPOSE: In most forms of open angle glaucoma, the trabecular meshwork is the main barrier for aqueous humor outflow, causing elevated intraocular pressure (IOP). The Trabectome is a minimal invasive device for the surgical treatment of open angle glaucoma, particularly eliminating the juxtacanalicular meshwork. This study was conducted to compare the effectiveness and complication profile among different glaucoma subgroups. METHODS: Single center prospective observational study. There were 557 consecutive eyes of 487 patients included in this study. Trabectome surgery was performed either alone or in combination with cataract surgery. Intraoperative and postoperative complications were documented systematically. Main outcome measures were IOP reduction over time and the preoperative and postoperative number of IOP-lowering medications. Due to subgroup sizes, only data from eyes with primary open angle glaucoma and pseudoexfoliation glaucoma were processed for statistical analysis. RESULTS: For the 261 eyes classified as primary open angle glaucoma, preoperative IOP was 24 ± 5.5 mmHg (mean ± SD) under 2.1 ± 1.3 IOP-lowering medications. After a mean follow-up of 204 ± 238 days, IOP was reduced to 18 ± 6.1 mmHg, and medication was reduced to 1.2 ± 1.1. For the 173 eyes classified as pseudoexfoliation glaucoma, after a mean follow-up of 200 ± 278 days, IOP was reduced from 25 ± 5.9 mmHg to 18 ± 8.2 mmHg, and medication was reduced from 2.0 ± 1.2 to 1.1 ± 1.1. A Cox proportional hazards model hinted forward superiority of the combined surgery cases (Trabectome + Phaco + intraocular lens) in comparison to Trabectome surgery only in phakic or pseudophakic eyes. No serious complications were observed. CONCLUSIONS: Minimal invasive glaucoma surgery with the Trabectome seems to be safe and effective. The subgroup analysis of different kinds of open angle glaucomas presented in this study may help in first-line patient selection. The lack of ocular surface alterations makes it a valuable addition to glaucoma surgery. Springer Berlin Heidelberg 2013-10-26 2013 /pmc/articles/PMC3889259/ /pubmed/24158374 http://dx.doi.org/10.1007/s00417-013-2500-7 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Glaucoma Jordan, Jens F. Wecker, Thomas van Oterendorp, Christian Anton, Alexandra Reinhard, Thomas Boehringer, Daniel Neuburger, Matthias Trabectome surgery for primary and secondary open angle glaucomas |
title | Trabectome surgery for primary and secondary open angle glaucomas |
title_full | Trabectome surgery for primary and secondary open angle glaucomas |
title_fullStr | Trabectome surgery for primary and secondary open angle glaucomas |
title_full_unstemmed | Trabectome surgery for primary and secondary open angle glaucomas |
title_short | Trabectome surgery for primary and secondary open angle glaucomas |
title_sort | trabectome surgery for primary and secondary open angle glaucomas |
topic | Glaucoma |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889259/ https://www.ncbi.nlm.nih.gov/pubmed/24158374 http://dx.doi.org/10.1007/s00417-013-2500-7 |
work_keys_str_mv | AT jordanjensf trabectomesurgeryforprimaryandsecondaryopenangleglaucomas AT weckerthomas trabectomesurgeryforprimaryandsecondaryopenangleglaucomas AT vanoterendorpchristian trabectomesurgeryforprimaryandsecondaryopenangleglaucomas AT antonalexandra trabectomesurgeryforprimaryandsecondaryopenangleglaucomas AT reinhardthomas trabectomesurgeryforprimaryandsecondaryopenangleglaucomas AT boehringerdaniel trabectomesurgeryforprimaryandsecondaryopenangleglaucomas AT neuburgermatthias trabectomesurgeryforprimaryandsecondaryopenangleglaucomas |